NASDAQ
ImmunoGen, Inc. (IMGN) has a free cash flow growth of 102.12% as of Friday, May 29, 2026. This represents a 6013.42% increase compared to its 12-month average of -1.73%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.